Justin H Turner1, Douglas D Reh. 1. Department of Otolaryngology-Head and Neck Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. justin.turner@jhmi.edu
Abstract
BACKGROUND: The present study uses population-based data from the Surveillance, Epidemiology, and End Results (SEER) database to evaluate the behavior of sinonasal tumors. METHODS: Data for all sinonasal malignancies reported between 1973 and 2006 (n = 6739) were extracted from the database. Time-dependent trends in incidence and survival were analyzed by linear regression. RESULTS: The overall incidence of sinonasal cancer was 0.556 cases per 100,000 population per year with a male:female ratio of 1.8:1. The most common histologies were squamous cell carcinoma (51.6%) and adenocarcinoma (12.6%), whereas the most common primary sites were the nasal cavity (43.9%) and maxillary sinus (35.9%). The incidence of sinonasal cancer remained relatively stable during the study period. No significant changes in overall relative survival were noted. The best relative survival was noted in patients treated with surgery or a combination of surgery and radiotherapy. CONCLUSIONS: The prognosis of patients with sinonasal cancer is generally poor, and has not changed substantially over the last 3 decades.
BACKGROUND: The present study uses population-based data from the Surveillance, Epidemiology, and End Results (SEER) database to evaluate the behavior of sinonasal tumors. METHODS: Data for all sinonasal malignancies reported between 1973 and 2006 (n = 6739) were extracted from the database. Time-dependent trends in incidence and survival were analyzed by linear regression. RESULTS: The overall incidence of sinonasal cancer was 0.556 cases per 100,000 population per year with a male:female ratio of 1.8:1. The most common histologies were squamous cell carcinoma (51.6%) and adenocarcinoma (12.6%), whereas the most common primary sites were the nasal cavity (43.9%) and maxillary sinus (35.9%). The incidence of sinonasal cancer remained relatively stable during the study period. No significant changes in overall relative survival were noted. The best relative survival was noted in patients treated with surgery or a combination of surgery and radiotherapy. CONCLUSIONS: The prognosis of patients with sinonasal cancer is generally poor, and has not changed substantially over the last 3 decades.
Authors: Hedyeh Ziai; Eugene Yu; Terence Fu; Nidal Muhanna; Eric Monteiro; Allan Vescan; Gelareh Zadeh; Ian J Witterick; David P Goldstein; Fred Gentili; John R de Almeida Journal: J Neurol Surg B Skull Base Date: 2017-12-29
Authors: Justin A Bishop; Theresa W Guo; David F Smith; Hao Wang; Takenori Ogawa; Sara I Pai; William H Westra Journal: Am J Surg Pathol Date: 2013-02 Impact factor: 6.394
Authors: Ming Fan; Jung Julie Kang; Anna Lee; Dan Fan; Huili Wang; Sarin Kitpanit; Pamela Fox; Kevin Sine; Dennis Mah; Sean M McBride; Chiaojung Jillian Tsai; Nadeem Riaz; Lara A Dunn; Eric J Sherman; Loren Michel; Bhuvanesh Singh; Ian Ganly; Richard J Wong; Jay O Boyle; Marc A Cohen; Nancy Y Lee Journal: Cancer Date: 2020-02-25 Impact factor: 6.860